← Back to Search

Catheter

Extended Dwell Catheters for Vascular Access Complications

N/A
Waitlist Available
Led By Amit Bahl, MD
Research Sponsored by William Beaumont Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Difficult vascular access defined as: patient has no visible veins (>2mm) or palpable veins
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during hospitalization, up to 30 days
Awards & highlights

Study Summary

This trial is comparing the two different ways to place an Extended Dwell Catheter (EDC) for blood sampling functionality.

Eligible Conditions
  • Peripheral Venous Access
  • Catheter-Related Infection or Complication
  • Vascular Access Complications

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have trouble finding or feeling your veins for blood draws or injections.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during hospitalization, up to 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and during hospitalization, up to 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood Sampling Functionality
Secondary outcome measures
Catheter Dwell time/Survival
Thrombosis

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental GroupExperimental Treatment1 Intervention
If the patient is randomized to the experimental group (lower arm), the research staff will direct the insert to place the catheter into the forearm at least 10 cm away from the antecubital fossa.
Group II: Control GroupActive Control1 Intervention
Control group (upper arm). If the patient is in the control group the research staff will direct the inserter to place the catheter into the upper arm vein at least 2 cm above the antecubital fossa.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Extended dwell catheters
2021
N/A
~100

Find a Location

Who is running the clinical trial?

William Beaumont HospitalsLead Sponsor
149 Previous Clinical Trials
112,936 Total Patients Enrolled
Amit Bahl, MDPrincipal Investigator - William Beaumont Hospitals
Beaumont Hospital-Royal Oak, William Beaumont Hospital
George Washington University School Of Medical & Hlth Sci (Medical School)
Schneider Children'S Hospital (Residency)
6 Previous Clinical Trials
1,199 Total Patients Enrolled

Media Library

Extended Dwell Catheter (Catheter) Clinical Trial Eligibility Overview. Trial Name: NCT04409418 — N/A
Peripheral Venous Access Research Study Groups: Experimental Group, Control Group
Peripheral Venous Access Clinical Trial 2023: Extended Dwell Catheter Highlights & Side Effects. Trial Name: NCT04409418 — N/A
Extended Dwell Catheter (Catheter) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04409418 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participant count for this research endeavor?

"Affirmative. Clinicaltrials.gov provides evidence that this clinical trial is actively looking for participants; the initial posting was on June 23rd 2021, and it has been modified as recently as October 28th 2022. The medical study aims to enrol 100 individuals from a single location."

Answered by AI

Is there availability for individuals to join the trial?

"Affirmative. Clinicaltrials.gov corroborates that this scientific investigation, initially shared on June 23rd 2021, is actively accepting applicants. One hundred individuals need to be recruited from one trial site."

Answered by AI
~27 spots leftby Mar 2025